Larson Financial Group LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1731061
ST LOUIS, MO
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$184,531
+$76,999 QoQ
Shares Held
613
+88.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#581
of 764 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Sep 30, 2023CallValue
$369
CallShares
900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $5,560,518 across 194 Biotechnology names. ALNY ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,302 | $646,742 | |
| 2 | INCY |
Incyte Corp
|
4,050 | $459,108 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,292 | $400,622 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
627 | $390,959 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,507 | $245,225 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,000 | $237,870 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
613 | $184,531 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
709 | $170,847 |
All Filings in ALNY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $184,531 | 613 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $107,532 | 325 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $95,833 | 241 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $136,800 | 300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $72,391 | 222 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $53,733 | 199 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $26,354 | 112 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $10,726 | 39 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,561 | 27 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,035 | 27 | Shares | Sole | 2024-05-03 | |
| 2023-09-30 | $369 | 900 | Call | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||